维普期刊资源整合服务平台（V6.5）

95篇 您的检索式：作者名="Nussmeier"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Impact of pexelizumab,an anti-C5 complement antibody,on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass显示文摘	Fitch JC Nussmeier NA	2004	Ann Thorac Surg2004，77，3：	1
2	Efficacy and safety of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery显示文摘	Ott E Nussmeier NA Duke PC	2003	J Thorac Cardiovasc Surg2003，125，6：	1
3	Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery显示文摘	NUSSMEIER N A WHELTON A A BROWN M T	2005	N Eng J Med2005，352，：	1
4	Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery显示文摘	Nussmeier NA Whelton AA Brown MT	2005	N Engl J Med2005，352，11：	1
5	Improving perioperative outcomes in patients withend-stage heart failure显示文摘	Nussmeier NA	2003	Rev Cardiovasc Med?2003，4，1：	1
6	Complication of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery 显示文摘	NUSSMEIER N A WHELTON A A BROWN M T	2005	N Engl J Med2005，352，：	1
7	Safety and efficacy of the cyclooxygenase - 2 inhibitors pare- coxib and valdecoxib after noncardiac surgery 显示文摘	Nussmeier NA Whehon AA Brown MT	2006	An- esthesiology2006，104，3：	1
8	Complication of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery显示文摘	Nussmeier NA Whelton AA Brown MT Langford RM Hoeft A Parlow JL	2005	N Engl J Med2005，352，：	1
9	Anesthetic management for implantation of the Jarvik 2000 left ventricular assist system显示文摘	Nussmeier NA Probert CB Hirsch D	2003	Anesth Analg2003，97，4：	1
10	Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after on cardiac surgery 显示文摘	Nussmeier NA Whelton AA Brown MT	2006	Anesthesiology2006，104，：	1
11	Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery显示文摘	Nussmeier N A Whelton A A Brown M T Langford R M Hoeft A Parlow J L	2005	N Engl J Med2005，352，：	1
12	Efficacy and safety of the cycloxygenate 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery显示文摘	Ott E Nussmeier NA Duke PC	2003	J Thorac Cardiovasc Surg2003，125，6：	1
13	Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecox- ib in patients undergoing coronary artery bypass surgery 显示文摘	Ott E Nussmeier NA Duke PC	2003	J Thorac Cardiovasc Surg2003，125，6：	1
14	Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery显示文摘	Nancy A Nussmeier NA Andrew A	2006	Anesthesiology2006，104，：	1
15	Adverse neurologic events: risks of intracardiacversus extracardiac surgery 显示文摘	Nussmeier NA	1996	J Cardiothorac Vase Anesth1996，10，1：	1
16	A review of risk factors for adverse neurologic outcome after cardiac surgery显示文摘	Nussmeier N A	2002	J Extra Corpor Technol2002，34，1：	1
17	A review of risk factors for adverse neurologic outcome after cardiac surgery显示文摘	Nussmeier N A	2002	J Extra Corpor Technol2002，34，6：	1
18	Adverse neurologic events:risk of intracardiac versus extracardiac surgery显示文摘	Nussmeier NA	1996	J Cardiothorac Vasc Anesth1996，10，：	1
19	Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery 显示文摘	OTT E NUSSMEIER N A DUKE P C	2003	J Thorac Cardiovasc Surg2003，125，6：	1
20	Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery 显示文摘	Ott E Nussmeier N A Duke P C etal	2003	J Thorac Cardiovasc Surg2003，125，6：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示